EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSJJAG00000018017
Gene Symbol: IDH1
3 Cross references
232 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSJJAG00000003839
Gene Symbol: IDH2
3 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSJJAG00000013422
Gene Symbol: KLKB1
3 Cross references
206 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSJJAG00000000119
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSJJAG00000000358
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSJJAG00000016860
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSJJAG00000010864
Gene Symbol: KIF5B
3 Cross references
280 Possible Orthologues:

Lectin, Galactose Binding, Soluble 1

Ensembl ID : ENSJJAG00000009972
Gene Symbol: LGALS1
1 Cross references
380 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSJJAG00000011318
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSJJAG00000012453
Gene Symbol: KDM1A
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSJJAG00000009230
Gene Symbol: LOXL2
3 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSJJAG00000000076
Gene Symbol: LOC101595723
3 Cross references
219 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).